Blood type may influence heart disease risk

August 14, 2012 in Cardiology

People with blood type A, B, or AB had a higher risk for coronary heart disease when compared to those with blood type O, according to new research published in Arteriosclerosis, Thrombosis and Vascular Biology, an American Heart Association journal.

People in this study with the rarest — AB, found in about 7 percent of the U.S. population — had the highest increased heart disease risk at 23 percent. Those with type B had an 11 percent increased risk, and those with type A had a 5 percent increased risk. About 43 percent of Americans have type O blood.

"While people cannot change their blood type, our findings may help physicians better understand who is at risk for developing heart disease," said Lu Qi, M.D., Ph.D., the study's senior author and an assistant professor in the Department of Nutrition at the Harvard School of Public Health in Boston.

Knowing your blood type can be an important part of staying healthy and avoiding heart disease, Qi said. "It's good to know your blood type the same way you should know your cholesterol or blood pressure numbers," he said. "If you know you're at higher risk, you can reduce the risk by adopting a healthier lifestyle, such as eating right, exercising and not smoking."

The findings are based on an analysis of two large, well-known U.S. studies — 62,073 women from the Nurses' Health Study and 27,428 adults from the Health Professionals Follow-up Study. Participants were between ages 30 and 75, and both groups were followed for 20 years or more.

Researchers also considered the study participants' diet, age, body mass index, gender, race, smoking status, menopause status and medical history. Researchers noted that the percentages of different blood types seen among the men and women enrolled in the two studies reflected levels seen in the general population.

The study did not evaluate the biological processes behind blood type and heart disease risk.

"Blood type is very complicated, so there could be multiple mechanisms at play," Qi said.

However, there is evidence suggesting that type A is associated with higher levels of low-density lipoprotein cholesterol, the waxy substance that can clog arteries, and type AB is linked to inflammation, which may affect the function of the blood vessels. Also, a substance that plays a favorable role in blood flow and clotting may be higher in people with type O blood.

Understanding blood type could help healthcare providers better tailor treatments, Qi suggested. For example, a patient with type A blood may best lower risk by decreasing cholesterol intake.

The study group was predominantly Caucasian, and it's not clear whether these findings would translate to other ethnic groups. Environment also contributes to risk, Qi said.

"It would be interesting to study whether people with different blood types respond differently to lifestyle intervention, such as diet," Qi said, noting that further analysis is needed.

Journal reference: Arteriosclerosis, Thrombosis and Vascular Biology search and more info website

Provided by American Heart Association search and more info website

3.7 /5 (3 votes)  

Rank 3.7 /5 (3 votes)
Relevant PhysicsForums posts

More news stories

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created 11 hours ago | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created 14 hours ago | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created 14 hours ago | popularity not rated yet | comments 0

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Cardiology created 14 hours ago | popularity not rated yet | comments 0

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...

Cardiology created May 21, 2013 | popularity 5 / 5 (1) | comments 0


Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.

Researchers complete largest genetic sequencing study of human disease

Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.

Having both migraines, depression may mean smaller brain

(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.

Novel approach for influenza vaccination shows promise in early animal testing

A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...

Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis

In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...